Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
Keywords: AnV, Annexin V; HCC, hepatocellular carcinoma; IAPs, Inhibitor of Apoptosis Proteins; PI, propidium iodine; PMSF, phenyl methyl sulfonyl fluoride; TACE, transarterial chemoembolizationLCL161; Hepatocellular carcinoma; JAK signalling; Paclitaxel; Combinato